[1]薛 磊,冉 宇,李忠泽,等.金天格胶囊治疗原发性骨质疏松症疗效研究[J].陕西中医,2023,(7):873-876.[doi:DOI:10.3969/j.issn.1000-7369.2023.07.010]
　XUE Lei,RAN Yu,LI Zhongze,et al.Effect study on Jintiange capsule in treatment of primary osteoporosis[J].,2023,(7):873-876.[doi:DOI:10.3969/j.issn.1000-7369.2023.07.010]
点击复制

金天格胶囊治疗原发性骨质疏松症疗效研究
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2023年7期
页码:
873-876
栏目:
临床研究
出版日期:
2023-07-05

文章信息/Info

Title:
Effect study on Jintiange capsule in treatment of primary osteoporosis
作者:
薛 磊1; 冉 宇2; 李忠泽2; 陈劲松2; 陈 江2
(1.中国中医科学院西苑医院创伤骨科,北京 100091; 2.北京中医药大学东直门医院骨伤科一区,北京 100700)
Author(s):
XUE Lei; RAN Yu; LI Zhongze; CHEN Jinsong; CHEN Jiang
(Department of Orthopaedic Trauma,Xiyuan Hospital,China Academy of Chinese Medical Sciences,Beijing 100091,China)
关键词:
原发性骨质疏松症;  钙尔奇D;  骨化三醇胶丸;  金天格胶囊;  骨代谢;  骨密度
Keywords:
Primary osteoporosis;  Calci D;  Calcitriol;  Jintiange capsule;  Bone metabolism;  Bone density
分类号:
R 274
DOI:
DOI:10.3969/j.issn.1000-7369.2023.07.010
文献标志码:
A
摘要:
目的:探讨原发性骨质疏松症(POP)经金天格胶囊治疗后的骨代谢变化。方法:采用随机数字表法将98例POP患者分为对照组、观察组,各49例。对照组给予钙尔奇D3、骨化三醇,观察组在对照组基础上给予金天格胶囊。两组均持续治疗6个月。比较两组治疗6个月后的临床疗效,治疗前、治疗6个月后的疼痛程度、中医症状积分、骨密度值、骨代谢指标、生活质量评分以及治疗期间的用药安全性。结果:治疗6个月后,观察组总有效率为95.92%,高于对照组的79.59%(P<0.05)。治疗6个月后,两组疼痛视觉模拟评分(VAS)、各项中医证候积分、血清碱性磷酸酶(ALP)水平均低于治疗前,且观察组低于对照组,差异有统计学意义(均P<0.05)。治疗6个月后,两组腰椎L2-4、股骨颈的骨密度T值、血钙(Ca)及骨钙素(OC)水平均高于治疗前,且观察组高于对照组,差异有统计学意义(均P<0.05)。治疗6个月后,两组简明健康状况量表(SF-36)评分高于治疗前; 治疗3个月后,观察组高于对照组,差异有统计学意义(均P<0.05)。两组治疗期间的不良反应总发生率比较,差异无统计学意义(P>0.05)。结论:金天格胶囊治疗POP可缓解临床症状,促进骨密度、骨代谢指标改善,使患者疼痛程度得以缓解,有效提高生活质量,具有较高的临床疗效,且安全性良好。
Abstract:
Objective:To investigate changes of bone metabolism in patients with primary osteoporosis(POP)before and after treatment with Jintiange capsule.Methods:98 patients with POP were divided into control group and observation group by random number table method,with 49 cases each group.The control group was given Calci D and calcitriol and the observation group given Jintiange capsule on the basis of the control group.Both groups were treated continuously for 6 months.After 6 months of treatment,the clinical efficacy,pain degree,TCM symptom score,bone density value,bone metabolism index,quality of life score,and drug safety during treatment were compared between the two groups.Results:After 6 months of treatment,the rate of total effective in the observation group was 95.92% higher than 79.59% in the control group(P<0.05).After 6 months treatment,the scores of visual analogue scale(VAS),traditional Chinese medicine syndrome and the levels of serum alkaline phosphatase(ALP)in the two groups were lower than before treatment,and the observation group lower than those in the control group,difference statistically significant(all P<0.05).The bone mineral density T value of the lumbar L2-4 and femoral neck,the levels of serum calcium(Ca)and osteocalcin(OC)were higher than before treatment,and the observation group higher than those in the control group,difference statistically significant(all P<0.05).After 6 months of treatment,the scores of short form of health(SF-36)in the two groups were higher than before and 3 months treatment,and the observation group higher than those in the control group,difference statistically significant(all P<0.05).There was no significant difference in the total incidence of adverse reactions between the two groups(P>0.05).Conclusion:Jintiange capsule treatment for POP could relieve clinical symptoms of patients,promote bone density and bone metabolism indicators,relieve the pain of patients,improve quality of life.It had high clinical efficacy with better safety.

参考文献/References:

[1] 薛 堃,邢秋娟,吴 佶,等.益气化瘀补肾方联合抗阻运动治疗原发性骨质疏松症疗效研究[J].陕西中医,2022,43(3):321-324.
[2] Argyrou C,Karlaftl E,Lampropoulou AK,et al.Effect of calcium and vitamin D supplementation with and without collagen peptides on bone turnover in postmenopausal women with osteopenia[J].Journal Musculoskelet Neuronal Interact,2020,20(1):12-17.
[3] 邱宏韬,林 青,赖文强,等.四烯甲萘醌软胶囊联合益肾固本祛痛汤治疗骨质疏松患者临床疗效[J].海南医学院学报,2019,25(14):1092-1095.
[4] 赵东波,王 昊,马育林,等.细胞因子配体3和绝经后骨质疏松症严重程度相关性研究[J].中国骨质疏松杂志,2020,26(12):1802-1805,1809.
[5] 中华医学会,中华医学会杂志社,中华医学会全科医学分会,等.原发性骨质疏松症基层诊疗指南[J].中华全科医师杂志,2020,19(4):316-323.
[6] 国家中医药管理局.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:356-360.
[7] 国家中医药管理局.中医病证诊断疗效标准[M].南京:南京大学出版社,1994:386.
[8] 徐王兵,李 勇,钟发明,等.两种脊柱微创手术治疗老年L5/S1椎间盘突出症疗效比较及对患者VAS及JOA评分的影响[J].陕西医学杂志,2020,49(1):72-75.
[9] 王 燕.老年膝骨关节炎合并骨质疏松患者生活质量状况及影响因素分析[J].中国骨质疏松杂志,2018,24(2):209-213.
[10] 张彤童,任龙喜,郭 函,等.高粘度骨水泥椎体成形术在骨质疏松性椎体压缩性骨折中临床应用价值研究[J].创伤与急危重病医学,2018,6(2):71-74.
[11] 彭山领,朱忠培.腰椎赘生物对中轴型脊柱关节炎骨质疏松评估的影响[J].成都医学院学报,2020,15(2):219-222.
[12] 戴蓉芳,冯月英,乔红梅,等.骨化三醇联合碳酸钙D3片治疗老年女性骨质疏松症效果观察[J].中华实用诊断与治疗杂志,2018,32(7):678-680.
[13] 赵志强,阎晓霞.中药补肾法改善原发性骨质疏松症临床症状的研究[J].中国骨质疏松杂志,2018,24(3):371-375,410.
[14] 陈佳汝,潘东晟,谭跃龙,等.阿仑膦酸钠联合金天格胶囊对女性骨质疏松症患者骨代谢指标的影响[J].中国医药,2019,14(8):1217-1221.
[15] 程金莲,张 翔,潘汉升,等.金天格胶囊治疗原发性骨质疏松症前瞻性多中心随机双盲对照临床试验[J].中华中医药学刊,2021,39(1):36-41.
[16] 岳建彪,苟 静,魏翾娣,等.中医综合疗法联合运动干预治疗老年绝经后骨质疏松症临床研究[J].陕西中医,2022,43(10):1380-1383.
[17] 张晓华,王 利,刘 丹,等.艾拉莫德治疗活动性类风湿关节炎合并骨量低下疗效及对患者骨代谢及外周血免疫指标的影响研究[J].陕西医学杂志,2021,50(4):482-484.
[18] 朱静栋,孔西建,吴 丹,等.骨松强骨方治疗肾阳虚血瘀型原发性骨质疏松症疗效观察[J].现代中西医结合杂志,2017,26(4):343-345,349.
[19] 方颖琪,沈 燚,张 奇,等.UP LC-Q-TOF-MS代谢组学探讨金天格胶囊防治骨质疏松症的机制[J].中国骨质疏松杂志,2022,28(6):848-856.
[20] 梁 爽,王忠霞,刘西哲,等.金天格胶囊治疗老年骨质疏松症的疗效观察[J].河北医药,2021,43(10):1501-1504.

相似文献/References:

[1]董 琪,张快强,昝 强,等.刘德玉教授论治原发性骨质疏松症经验*[J].陕西中医,2020,(2):226.
[2]薛 堃,邢秋娟,吴 佶,等.益气化瘀补肾方联合抗阻运动治疗原发性骨质疏松症疗效研究[J].陕西中医,2022,(3):321.[doi:DOI:10.3969/j.issn.1000-7369.2022.03.012]
　XUE Kun,XING Qiujuan,WU Ji,et al.Effect of Yiqi Huayu Bushen decoction combined with anti-obstructive exercise in the treatment of primary osteoporosis[J].,2022,(7):321.[doi:DOI:10.3969/j.issn.1000-7369.2022.03.012]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金资助项目(81603638); 北京中医药大学东直门医院横向课题(HX-DZM-202134)
更新日期/Last Update: 2023-07-10